Clinical Trials
November 28, 2024

FHI Clinical & TASK unite to deliver comprehensive oncology trial solution

We are thrilled to announce a strategic partnership between FHI Clinical, a globally recognized CRO, and TASK, a premier multi-site clinical research institution with a presence in Europe and South Africa. Together, we’re combining FHI Clinical’s global clinical research expertise with TASK’s cutting-edge infrastructure and operational excellence to deliver turnkey solutions for oncology clinical trials.

Oncology clinical trial

This partnership is designed to meet the growing demand for oncology research, tapping into South Africa’s diverse, treatment-naïve population and its advanced clinical sites. With South Africa’s age-standardized cancer rate at 203.4 per 100,000 people¹, we see an incredible opportunity to accelerate cancer treatments and bring innovative therapies to patients in need.

  • By aligning our strengths, we’re able to offer:
  • Seamless, high-quality trial management from study design through to execution
  • Accelerated study timelines through streamlined regulatory approvals and site start-ups
  • Access to top-tier investigators and facilities
  • A shared commitment to improving healthcare globally

Our combined experience in oncology research, paired with our established presence in South Africa, ensures efficient patient recruitment, superior clinical oversight, and world-class facilities. Together, we’re creating a powerful platform for advancing cancer research and delivering life-saving therapies to patients faster.

We are excited to work towards a shared goal of better healthcare for all!

1 Reference: Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer.
Available from: https://lnkd.in/dbFemzCM, accessed 2 October 2024.

Doctor with mobile device

Don't hesitate to get in touch with us if you have any questions or concerns.

Learn more
Doctor with mobile device